Thomas G. Gesner
Impact in
- Hematology top 10%
-
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
Papers in
-
- DNA Repair Mechanisms 3
- Cancer therapeutics and mechanisms 2
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
- Co-authors
- R. Allan Mufson (4 shared papers)Laura S. Angelo (1 shared paper)Laurie B. Owen‐Schaub (1 shared paper)Robert Radinsky (1 shared paper)David Bartos (1 shared paper)Bernhard Wörmann (1 shared paper)Tucker W. LeBien (1 shared paper)Carl F. Ware (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Cellular Physiology (2 papers)Cancer Letters (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Thomas G. Gesner
16 papers receiving 573 citations
Peers
Comparison fields: 5 of 65
- Hematology 84
- Immunology 155
- Oncology 170
- Geriatrics and Gerontology 15
- Toxicology 14
Countries citing papers authored by Thomas G. Gesner
This map shows the geographic impact of Thomas G. Gesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Gesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Gesner more than expected).
Fields of papers citing papers by Thomas G. Gesner
This network shows the impact of papers produced by Thomas G. Gesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Gesner. The network helps show where Thomas G. Gesner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas G. Gesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 117 | |
| 2 | 1995 | 94 | |
| 3 | Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. | 1989 | 63 |
| 4 | 2006 | 58 | |
| 5 | 1988 | 52 | |
| 6 | 1988 | 31 | |
| 7 | 2018 | 29 | |
| 8 | 1989 | 27 | |
| 9 | 2008 | 26 | |
| 10 | 2016 | 24 | |
| 11 | 2011 | 24 | |
| 12 | Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse. | 1999 | 20 |
| 13 | 2016 | 17 | |
| 14 | 2006 | 16 | |
| 15 | 2006 | 4 | |
| 16 | 2016 | 1 |
About Thomas G. Gesner
Thomas G. Gesner is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Cell Biology, having authored 16 papers that have together received 603 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Immune Cell Function and Interaction (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer therapeutics and mechanisms (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Hematology (84 citations), Immunology (155 citations), Oncology (170 citations), Geriatrics and Gerontology (15 citations) and Toxicology (14 citations). Thomas G. Gesner has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include R. Allan Mufson, Laura S. Angelo, Laurie B. Owen‐Schaub, Robert Radinsky, David Bartos, Bernhard Wörmann, Tucker W. LeBien, Carl F. Ware, Sylvia Ma and Steven C. Clark. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Journal of Cellular Physiology, Cancer Letters and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.